---All---
  • ---All---
  • Accession
  • Catalog #

FGFR1 Antibody (C-term) Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP7636b 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

FGFR1 Antibody (C-term) Blocking Peptide - Product info

Primary AccessionP11362
Clone Names2062606
Calculated MW91868 Da

FGFR1 Antibody (C-term) Blocking Peptide - Additional info

Gene ID 2260
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP7636b was selected from the C-term region of human FGFR1 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

FGFR1 Antibody (C-term) Blocking Peptide - Protein Information

Name FGFR1
Synonyms BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR
Function
Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2 In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation
Cellular Location
Cell membrane; Single-pass type I membrane protein. Nucleus. Cytoplasm, cytosol. Cytoplasmic vesicle Note=After ligand binding, both receptor and ligand are rapidly internalized. Can translocate to the nucleus after internalization, or by translocation from the endoplasmic reticulum or Golgi apparatus to the cytosol, and from there to the nucleus
Tissue Location
Detected in astrocytoma, neuroblastoma and adrenal cortex cell lines. Some isoforms are detected in foreskin fibroblast cell lines, however isoform 17, isoform 18 and isoform 19 are not detected in these cells

FGFR1 Antibody (C-term) Blocking Peptide - Related products

AP3104a: Phospho-FGFR-pY653/654 Antibody

AP3105a: Phospho-FGFR-Y766 Antibody

AP3105b: Phospho-FGFR1-pY766 Antibody

AP3311a: Phospho-FGFR1-Y307 Antibody

AP3312a: Phospho-FGFR1-Y463 Antibody

AP3313a: Phospho-FGFR1-Y654 Antibody

AP3420a: Phospho-FGFR1-pY154 Antibody

AP3755a: Phospho-FGFR- Y653 Antibody

AP7636b: FGFR1 Antibody (C-term)

AP7636d: FGFR1 Antibody (Y463)

AP7636e: FGFR1 Antibody (Y654)

AP7636f: FGFR1 Antibody (Y766)

AP7636g: FGFR1 Antibody (Y653)

AP7636h: FGFR1 Antibody (Y154)

AP7636i: FGFR1 Antibody (C-term)

AP9814a: FGFR1-Y307 Antibody

RI11993: FGFR1 predesign siRNA

LY10425a: FGFR1 Over-expression Lysate

BP3104a: Phospho-FGFR-Y653/654 Antibody Blocking Peptide

BP3105a: Phospho-FGFR-Y766 Antibody Blocking Peptide

BP3105b: Phospho-FGFR1-pY766 Antibody Blocking Peptide

BP3311a: Phospho-FGFR1-Y307 Antibody Blocking Peptide

BP3312a: Phospho-FGFR1-Y463 Antibody Blocking Peptide

BP3313a: Phospho-FGFR1-Y654 Blocking Peptide

BP3420a: Phospho-FGFR1-pY154 Antibody Blocking Peptide

BP7636a: FGFR1 Antibody (N-term) Blocking Peptide

BP7636b: FGFR1 Antibody (C-term) Blocking Peptide

BP7636d: FGFR1 Antibody (Y463) Blocking Peptide

BP7636e: FGFR1 Antibody (Y654) Blocking Peptide

BP7636f: FGFR1 Antibody (Y766) Blocking Peptide

BP7636g: FGFR1 Antibody (Y653) Blocking Peptide

BP7636h: FGFR1 Antibody (Y154) Blocking Peptide

BP9814a: FGFR1-Y307 Antibody Blocking Peptide

AO1289a: FGFR1 Antibody

AJ1291a: FGF-1 Antibody (C-term)

AF1411a: FGFR1 Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

FGFR1 is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene can lead to Pfeiffer syndrome and Jackson-Weiss syndrome. The genomic organization of the gene is very similar to family members 2-4, encompassing 19 exons that are subject to complex alternative splicing, which allows for structural, tissue expression and ligand affinity variations among the isoforms.

REFERENCES

Jiao, J., et al., Arch. Biochem. Biophys. 410(2):187-200 (2003).Fu, L., et al., J. Comp. Neurol. 462(2):265-273 (2003).Lundin, L., et al., Exp. Cell Res. 287(1):190-198 (2003).Kiselyov, V.V., et al., Structure (Camb.) 11(6):691-701 (2003).Baumann, H., et al., J. Biol. Chem. 278(18):16198-16208 (2003).